Stocks
Attain IncATTU
HealthcarePharmaceuticals
A specialty pharmaceutical company focused on developing and commercializing treatments for central nervous system disorders, including attention deficit hyperactivity disorder. Its lead product candidates target unmet needs in the ADHD market, and investors track the company for its clinical pipeline and regulatory milestones.
Congressional Interest in Attain Inc (ATTU)
1 member of Congress has disclosed 1 trade in Attain Inc (ATTU), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading ATTU?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-06-25 | MICHAEL T. MCCAUL | sell | $1K-$15K |